JAZZ Jazz Pharmaceuticals plc
Price Chart
Executive Summary
Director Anne O'Riordan informed Jazz Pharmaceuticals' board that she will not stand for re-election at the 2026 annual meeting. The filing explicitly states her decision was not due to any dispute or disagreement with the company. This is a routine board refreshment event with no material impact on operations or strategy.
Actionable Insight
No trading action warranted. Monitor the 2026 proxy statement for any board composition changes or new director nominees, but this single departure is immaterial to JAZZ's fundamentals or near-term outlook.
Key Facts
- Anne O'Riordan, a Class III director, will not stand for re-election at the 2026 annual meeting
- Decision was not the result of any dispute or disagreement with the company or board
- Board will continue to evaluate composition and facilitate orderly succession
- No replacement named in the filing
Financial Impact
No financial impact — routine director departure with no compensation or operational changes disclosed
Risk Factors
- Potential loss of board expertise if O'Riordan's departure is not offset by a qualified replacement
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-039147 |
| Document: 0001628280-26-039147-index-headers.html | 0001628280-26-039147 |
| Document: 0001628280-26-039147-index.html | 0001628280-26-039147 |
| Document: 0001628280-26-039147.txt | 0001628280-26-039147 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
6d ago
|
DEFA14A
| $231.98 awaiting T+1 | awaiting T+1 | — | $230.56 (−0.61%) |
|
Jun 3, 2026
11d ago
|
Insider Cluster
| $239.17 $238.57 | ▲ +0.25% | ▼ −2.32% | $230.56 (+3.60%) |
|
Jun 3, 2026
11d ago
|
Insider Cluster
| $240.06 $238.57 | ▼ −0.62% | ▲ +1.98% | $230.56 (−3.96%) |
|
Jun 1, 2026
13d ago
|
144
| $226.12 $230.93 | ▲ +2.13% | ▲ +2.85% | $230.56 (+1.96%) |
|
May 29, 2026
16d ago
|
8-K
| $231.19 $226.12 | ▼ −2.19% | ▼ −2.34% | $230.56 (−0.27%) |
|
May 1, 2026
6w ago
|
144
| $202.51 $207.89 | ▲ +2.66% | ▲ +3.00% | $230.56 (+13.85%) |
|
Apr 24, 2026
7w ago
|
10-K/A
| $200.31 $203.07 | ▲ +1.38% | ▲ +1.86% | $230.56 (+15.10%) |
|
Apr 1, 2026
10w ago
|
144
| $186.73 $185.83 | ▼ −0.48% | ▼ −0.96% | $230.56 (+23.47%) |
|
Feb 27, 2026
15w ago
|
Insider Cluster
| $189.00 $190.30 | ▲ +0.69% | ▲ +0.63% | $230.56 (+21.99%) |
|
Feb 27, 2026
15w ago
|
Insider Cluster
| $189.00 $190.30 | ▲ +0.69% | ▲ +0.63% | $230.56 (+21.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access